期刊文献+

抗甲胎蛋白抗体与氟尿嘧啶联接治疗肝癌的Ⅰ期临床试验 被引量:3

A PHASE 1 STUDY OF ANTI-AFP ANTIBODY JOINING FLUOROURACL THERAPY IN LIVER CANCER
下载PDF
导出
摘要 用戊二醛将5-Fu与抗AFP IgG联接。该免疫联接物体外细胞毒试验表明对产生人AFP的Alexander细胞的细胞毒作用比单纯药物增强约2000倍,而对AFP阴性的K_(562)细胞的细胞毒作用与单纯药物和单纯抗体无明显差异。5例病理诊断为肝细胞肝癌,AFP阳性病人用5-Fu-抗AFPIgG免疫联接物治疗,结果有2例病人血清AFP含量下降。未发生变态反应,亦未见有明显副作用及对肝肾的损害。 Flurouacil was joined to anti-AFP IgG by glutaraldehyde. This immunoconjugate in vitro cytotoxic test showed cytotoxicity for human HCC cell line(Alexander line)which was AFP positive,but with out cytoto- xity for AFP negative K_(562) cell line.The cytotoxity of the immunoconjugate for Alexander cells was much higher(about 2000 times)than fluorouracil alone. Five pathologically proven HCC patients who were AFP positive were treat- ed with this immunoconjugate.Serum AFP level was found decreasing in two patients.No allergy was noted.No marked side effects,neither clinical ma- nifestations of the kidney nor liver damages had been observed.
出处 《广西医学院学报》 1990年第3期5-8,共4页
关键词 抗AFP抗体 氟尿嘧啶 肝癌 Anti-AFP antibody Flurouracil immunoconjugate Hepatocellular carcinoma
  • 相关文献

参考文献1

  • 1祝鸿耀,张冀先,翁是强,吴伯惠,毛敏华,屠之培,臧珍秀.甲胎蛋白分泌性肿瘤的正相定位诊断——放射免疫探测法[J]肿瘤,1985(04).

同被引文献7

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部